2025. Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome. Biomolecules and Biomedicine. 25, 5 (Apr. 2025), 1175–1183. DOI:https://doi.org/10.17305/bb.2025.11564.